|
1
|
Henley DB, Dowsett SA, Chen YF,
Liu-Seifert H, Grill JD, Doody RS, Aisen P, Raman R, Miller DS,
Hake AM, et al: Alzheimer's disease progression by geographical
region in a clinical trial setting. Alzheimers Res Ther. 7:432015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dong MJ, Peng B, Lin XT, Zhao J, Zhou YR
and Wang RH: The prevalence of dementia in the People's Republic of
China: a systematic analysis of 1980–2004 studies. Age Ageing.
36:619–624. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barage SH and Sonawane KD: Amyloid cascade
hypothesis: pathogenesis and therapeutic strategies in Alzheimer's
disease. Neuropeptides. 52:1–18. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sadigh-Eteghad S, Sabermarouf B, Majdi A,
Talebi M, Farhoudi M and Mahmoudi J: Amyloid-beta: a crucial factor
in Alzheimer's disease. Med Princ Pract. 24:1–10. 2015. View Article : Google Scholar
|
|
5
|
Shen ZY, Xu LY, Li EM, Li JT, Chen MH,
Shen J and Zeng Y: Ezrin, actin and cytoskeleton in apoptosis of
esophageal epithelial cells induced by arsenic trioxide. Int J Mol
Med. 12:341–347. 2003.PubMed/NCBI
|
|
6
|
Rudrabhatla P: Regulation of neuronal
cytoskeletal protein phosphorylation in neurodegenerative diseases.
J Alzheimers Dis. 41:671–684. 2014.PubMed/NCBI
|
|
7
|
Kaminsky YG, Marlatt MW, Smith MA and
Kosenko EA: Subcellular and metabolic examination of amyloid-beta
peptides in Alzheimer disease pathogenesis: evidence for
Abeta(25–35). Exp Neurol. 221:26–37. 2010. View Article : Google Scholar
|
|
8
|
Pike CJ, Walencewicz AJ, Glabe CG and
Cotman CW: In vitro aging of beta-amyloid protein causes peptide
aggregation and neurotoxicity. Brain Res. 563:311–314. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hatok J, Babusikova E, Matakova T, Mistuna
D, Dobrota D and Racay P: In vitro assays for the evaluation of
drug resistance in tumor cells. Clin Exp Med. 9:1–7. 2009.
View Article : Google Scholar
|
|
10
|
Ndozangue-Touriguine O, Hamelin J and
Bréard J: Cytoskeleton and apoptosis. Biochem Pharmacol. 76:11–18.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gourlay CW, Carpp LN, Timpson P, Winder SJ
and Ayscough KR: A role for the actin cytoskeleton in cell death
and aging in yeast. J Cell Biol. 164:803–809. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dekkers MP, Nikoletopoulou V and Barde YA:
Cell biology in neuroscience: death of developing neurons: new
insights and implications for connectivity. J Cell Biol.
203:385–393. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen A, Xiong LJ, Tong Y and Mao M: The
neuroprotective roles of BDNF in hypoxic ischemic brain injury.
Biomed Rep. 1:167–176. 2013. View Article : Google Scholar
|
|
14
|
Loo DT, Copani A, Pike CJ, Whittemore ER,
Walencewicz AJ and Cotman CW: Apoptosis is induced by beta-amyloid
in cultured central nervous system neurons. Proc Natl Acad Sci USA.
90:7951–7955. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim IK, Lee KJ, Rhee S, Seo SB and Pak JH:
Protective effects of peroxiredoxin 6 overexpression on amyloid
β-induced apoptosis in PC12 cells. Free Radic Res. 10:836–846.
2013. View Article : Google Scholar
|
|
16
|
Green DR and Llambi F: Cell death
signaling. Cold Spring Harb Perspect Biol. 7:72015. View Article : Google Scholar
|
|
17
|
Leadsham JE, Kotiadis VN, Tarrant DJ and
Gourlay CW: Apoptosis and the yeast actin cytoskeleton. Cell Death
Differ. 17:754–762. 2010. View Article : Google Scholar
|
|
18
|
Hardy J: Has the amyloid cascade
hypothesis for Alzheimer's disease been proved. Curr Alzheimer Res.
3:71–73. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Henriques AG, Vieira SI, da Cruz E Silva
EF and da C ruz E Silva OA: Abeta promotes Alzheimer's
disease-like cytoskeleton abnormalities with consequences to APP
processing in neurons. J Neurochem. 113:761–771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jin M, Shepardson N, Yang T, Chen G, Walsh
D and Selkoe DJ: Soluble amyloid beta-protein dimers isolated from
Alzheimer cortex directly induce Tau hyperphosphorylation and
neuritic degeneration. Proc Natl Acad Sci USA. 108:5819–5824. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sohn PD, Tracy TE, Son HI, Zhou Y, Leite
RE, Miller BL, Seeley WW, Grinberg LT and Gan L: Acetylated Tau
destabilizes the cytoskeleton in the axon initial segment and is
mislocalized to the somatodendritic compartment. Mol Neurodegener.
11:472016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Deng Y, Wei J, Cheng J, Zhong P, Xiong Z,
Liu A, Lin L, Chen S and Yan Z: Partial amelioration of synaptic
and cognitive deficits by inhibiting cofilin dephosphorylation in
an animal model of Alzheimer's disease. J Alzheimers Dis.
53:1419–1432. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ostrovskaya RU, Vakhitova YV, Kuzmina US,
Salimgareeva MK, Zainullina LF, Gudasheva TA, Vakhitov VA and
Seredenin SB: Neuroprotective effect of novel cognitive enhancer
noopept on AD-related cellular model involves the attenuation of
apoptosis and Tau hyperphosphorylation. J Biomed Sci. 21:742014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thomas SG, Huang S, Li S, Staiger CJ and
Franklin-Tong VE: Actin depolymerization is sufficient to induce
programmed cell death in self-incompatible pollen. J Cell Biol.
174:221–229. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu J, Zhang R, Zuo P, Yang N, Ji C, Liu W,
Wang Y, Wang H, Wu A, Yue Y, et al: Aggravation effect of
isoflurane on Aβ(25–35)-induced apoptosis and Tau
hyperphosphorylation in PC12 cells. Cell Mol Neurobiol.
32:1343–1351. 2012. View Article : Google Scholar : PubMed/NCBI
|
